Brief: Index Pharmaceuticals Holding Q3 Oper Loss Narrows To SEK 4.5 Mln
Nov 23 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* INDEX PHARMACEUTICALS HOLDING AB (PUBL) INTERIM REPORT
JANUARY -
SEPTEMBER 2022
* Q3 NET SALES SEK 0.0 MILLION VERSUS SEK 0.0 MILLION YEAR
AGO
* Q3 OPERATING LOSS SEK 4.5 MILLION VERSUS LOSS SEK 28.2
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrbKYZN2
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen